Dr. Manish Janardhan Butte, MD, PhD

  • Los Angeles, CA
  • Pediatric allergy/immunology physician
NPI1801861216PAC ID7416950639
Part D claims, 2024
49
Publications
120
Clinical trials
3
MIPS score, 2024
78
Hospital affiliations
1
Practice address
200 Medical Plz, Los Angeles, CA 90024
Practice phone
Call (310) 794-9206
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Peter Morton UCLA Medical Building

Los Angeles, California

See all 4 affiliations

Find Dr. Butte's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Manish Janardhan Butte is a pediatric allergy/immunology physician in Los Angeles, California

Dr. Butte practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Butte's NPI, 1801861216, was assigned on February 20, 2006. Dr. Butte graduated from Warren Alpert Medical School of Brown University in 1996. Dr. Butte holds California license A110453.

NPI and contact details
Medicare PAC ID
7416950639
NPI enumeration date
February 20, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(310) 794-9206
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
56
Medical school graduation
1996

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Manish Janardhan Butte practices at Peter Morton UCLA Medical Building in Los Angeles, California

Dr. Butte's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

  • Peter Morton UCLA Medical Building
    200 Medical Plz, Los Angeles, CA 90024 · Los Angeles CountyPhone(310) 794-9206

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Manish Janardhan Butte is affiliated with 3 sites of care and 1 medical group

Dr. Butte's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Butte is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Health. Dmand AI also links Dr. Butte to 1 more group practice or clinic, named with a free account.

See all 4 affiliations for Dr. Butte

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Manish Janardhan Butte's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Butte practices, 2 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Peter Morton UCLA Medical BuildingAvailable with a free account
+2 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Butte practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Manish Janardhan Butte is one of 49 pediatric allergy/immunology physicians in California

Pediatric allergy/immunology is Dr. Butte's primary specialty in the NPI Registry, under taxonomy code 2080P0201X. Dr. Butte is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dmand AI has Dr. Butte's licenses on file in 3 states: California, Massachusetts and Pennsylvania.

Specialties and state licenses

  • Pediatric allergy/immunology, CaliforniaPrimaryLicense A110453 · 2009 to 2027 · taxonomy 2080P0201X
  • Massachusetts license2003 to 2010
  • Pennsylvania license2002 to 2004

Pediatric allergy/immunology physicians near Dr. Butte

Counts of pediatric allergy/immunology physicians with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Manish Janardhan Butte's patients have a median age of 24

Across all payers, Dmand AI patient panel data puts Dr. Butte's median patient age at 24, with 51% women.

Dr. Butte's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 24

Patient panel by sex, all payers

  • Women51%
  • Men46%

Source: Dmand AI Patient Panel Data

Dr. Manish Janardhan Butte wrote 49 Medicare Part D claims in 2024

In 2024, Dr. Butte wrote 49 Medicare Part D claims. 61% of them were for generic drugs. CMS names the drug for 28 of them, across 2 drugs with 11 or more claims each, at $116,205 in total drug cost. In 2023, CMS named 14 claims across 1 drug.

Part D claims, 202449
Drugs named by CMS2
Total drug cost$116,205

Dr. Butte's Part D claims by kind of drug, 2024

  • Generic30 claims61%
  • Brand-name19 claims39%

Dr. Butte's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Butte's Part D claims, 2024

  • Antibiotics39%19 of 49 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 142024: 28100%

Drugs named by CMS: 2 in 2024, 1 in 2023.

See all prescribing by Dr. Butte

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Manish Janardhan Butte scored 78 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 78 out of 100 for Dr. Butte for performance year 2024, reported as part of a group. Dr. Butte accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Dr. Butte's MIPS scores, performance year 2024

  • 78of 100Final score
  • 82.1of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 10of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find pediatric allergy/immunology physicians like Dr. Butte by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Manish Janardhan Butte has 120 publications on record

Dmand AI links 120 papers to Dr. Butte, published from 2007 to 2025. 2016 was the busiest year, with 12. The most frequent topics are Lymphocyte Activation, T-Lymphocytes and Cells, Cultured. Dr. Butte has published most often in Front Immunol. Dr. Butte's most frequent co-authors are Jolan E. Walter, MD, Luigi Notarangelo, MD and Paul Laszlo Bollyky, MD, PhD.

Papers120
Years published2007 to 2025

Dr. Butte's papers by year, 2016 to 2025

Topics Dr. Butte writes about most

  • Lymphocyte Activation
  • T-Lymphocytes
  • Cells, Cultured
  • Signal Transduction
  • Mice, Inbred C57BL
  • Cell Line
  • Microscopy, Atomic Force
  • Biomechanical Phenomena

Dr. Butte's most frequent co-authors

Recent publications by Dr. Butte

See all 120 publications and co-authors

See who Dr. Butte researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Butte works with, so you can find a warm path to the right pediatric allergy/immunology physicians.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Manish Janardhan Butte has worked on 3 clinical trials

Dmand AI links Dr. Butte to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Common Variable Immunodeficiency, Severe combined immunodeficiency due to adenosine deaminase deficiency and Primary Immunodeficiency Diseases.

Conditions in Dr. Butte's trials

  • Common Variable Immunodeficiency
  • Severe combined immunodeficiency due to adenosine deaminase deficiency
  • Primary Immunodeficiency Diseases

Investigators on the most trials with Dr. Butte

Recent clinical trials with Dr. Butte

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Manish Janardhan Butte received $376,792 in industry payments from 2017 to 2025

CMS Open Payments shows 445 general payments to Dr. Butte from 22 drug and device companies from 2017 to 2025. Speaker and faculty fees make up the largest share, 36% of the total. Grifols Shared Services North America, Inc. paid the most, $156,056. It also lists 4 research payments totaling $26,963 from 2022 to 2024.

General payments to Dr. Butte by program year, 2017 to 2025

General payments to Dr. Butte by kind, 2017 to 2025

$376.8Kin total
  • Speaker and faculty fees$135,04336%
  • Honoraria$106,61528%
  • Consulting fees$73,10719%
  • Travel and lodging$45,72412%
  • Other$16,3034%

Companies that paid Dr. Butte the most, 2017 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Butte

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Manish Janardhan Butte graduated from Warren Alpert Medical School of Brown University

Dr. Butte graduated from Warren Alpert Medical School of Brown University in 1996. Dr. Butte is a member of Clinical Immunology Society.

  1. Medical schoolWarren Alpert Medical School of Brown University
  2. Board certified in allergy & immunologyAmerican Board of Allergy and Immunology
  3. Board certified in pediatricsAmerican Board of Pediatrics

Source: Dmand AI Professional Profile Data

Dr. Manish Janardhan Butte accepts plans from 13 insurance carriers

Dr. Butte is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.

  • Aetna
  • Elevance
  • Blue Cross Blue Shield of Michigan
  • United Healthcare
  • HCSC
  • Blue Cross Blue Shield of Massachusetts
  • Regence Health Plans
  • Alliant Health Plans
  • +5 more carriersWith a free account

Plan types Dr. Butte accepts, by number of carriers

  1. Medicare8
  2. HMO7
  3. PPO7
  4. EPO4
  5. POS4
  6. Medicaid1

Source: Dmand AI Insurance Network Data

Sources for Dr. Manish Janardhan Butte's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare patients and the all-payer patient panelDmand AI Patient Panel Data
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Manish Janardhan Butte

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Manish Janardhan Butte's NPI number?

Dr. Manish Janardhan Butte's NPI number is 1801861216. It was assigned on February 20, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Manish Janardhan Butte?

Dr. Manish Janardhan Butte is a pediatric allergy/immunology physician in Los Angeles, California. The primary specialty in the NPI Registry is Pediatric Allergy/Immunology Physician (taxonomy code 2080P0201X).

Where does Dr. Manish Janardhan Butte practice?

Dr. Butte practices at 200 Medical Plz, Los Angeles, CA 90024. Dr. Butte's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dmand AI also links Dr. Butte to 1 group practice or clinic.

What is Dr. Manish Janardhan Butte's office phone number?

The practice phone on file for Dr. Butte is (310) 794-9206.

What is Dr. Manish Janardhan Butte's medical license number?

Dr. Butte holds California license A110453, one of the licenses on file in 3 states.

Which states has Dr. Manish Janardhan Butte been licensed in?

Dmand AI has state licenses on file for Dr. Butte in California (2009 to 2027), Massachusetts (2003 to 2010) and Pennsylvania (2002 to 2004).

Which hospitals is Dr. Manish Janardhan Butte affiliated with?

Dr. Butte is affiliated with Ronald Reagan UCLA Medical Center.

What medical group is Dr. Manish Janardhan Butte part of?

Dr. Butte is linked to UCLA Health.

Does Dr. Manish Janardhan Butte accept Medicare?

Yes. CMS lists Dr. Butte as accepting Medicare assignment.

What is Dr. Manish Janardhan Butte's MIPS score?

Dr. Butte's MIPS final score for performance year 2024 is 78 out of 100, reported as part of a group.

Show 8 more questionsShow fewer questions

Is Dr. Manish Janardhan Butte board certified?

Yes. Dr. Butte is board certified in allergy & immunology by the American Board of Allergy and Immunology.

Where did Dr. Manish Janardhan Butte go to medical school?

Dr. Butte graduated from Warren Alpert Medical School of Brown University in 1996.

What drugs does Dr. Manish Janardhan Butte prescribe most?

In 2024 Medicare Part D data, Dr. Butte's most prescribed drugs by claims were Hizentra and Doxycycline Hyclate.

Has Dr. Manish Janardhan Butte received payments from drug or device companies?

CMS Open Payments shows $376,792 in general payments to Dr. Butte from 22 companies from 2017 to 2025. The largest total came from Grifols Shared Services North America, Inc.

How long has Dr. Manish Janardhan Butte been practicing?

Dr. Butte graduated from medical school in 1996, 30 years ago.

Does Dr. Manish Janardhan Butte do research?

Dmand AI links 120 publications to Dr. Butte, published from 2007 to 2025. Dr. Butte has worked on 3 clinical trials.

Who does Dr. Manish Janardhan Butte publish with?

Dr. Butte's most frequent co-authors are Jolan E. Walter, MD (12 shared papers), Luigi Notarangelo, MD (11 shared papers) and Paul Laszlo Bollyky, MD, PhD (9 shared papers).

What insurance does Dr. Manish Janardhan Butte accept?

Dr. Butte is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.

Selling to pediatric allergy/immunology practices?

See pediatric allergy/immunology physicians in California by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)